ArticleMalaria journal2025
Complete gene sequence diversity, amplification, and natural selection of the Plasmodium vivax Duffy binding protein locus.
Article in Malaria journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Contrasting evolutionary trajectories of pyrimethamine resistance in human and zoonotic malaria parasites.Malaria journal · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundThe Duffy binding ligand domain of Plasmodium vivax (PvDBPII) interacts with Duffy blood-group antigen on the surface of reticulocytes during host cell invasion process. Although diversity of this domain has been analysed among worldwide isolates, the evolution of the complete PvDBP gene remains to be explored.
methodsIn total, 232 P. vivax isolates from northwestern, northeastern, eastern, and southern Thailand were included for analyses of the complete gene sequence, copy number variation and duplication genotypes of Pvdbp. The Duffy blood-group genotypes of the patient were also determined.
resultsPvdbp duplication, all of the Cambodian type, was detected in 22 isolates (9.48%), characterized by identical copies (n = 17) and microheterogeneity between copies (n = 5). Across 254 sequences including duplicated copies, nucleotide diversity was highest in PvdbpII. Positive selection, evidenced by excess nonsynonymous over synonymous substitutions, occurred in both the 5' region and PvdbpII. Codon-based analysis revealed 26 positively selected codons distributed across the protein; 22 of these overlapped predicted B cell and/or T cell epitopes. Insertions and deletions including frameshift mutations were found outside PvdbpII apart from an indel in this domain, while recombination breakpoints were confined to PvdbpII and the 3' region. Parasite isolates from each endemic region displayed population structure. No significant difference in Duffy phenotype frequencies was found between malaria patients in this study and healthy blood donors from reported data.
conclusionsWhile PvdbpII remains the most variable domain, sequence diversity occurred outside this domain. Cambodian-type Pvdbp duplications, often with identical sequences, may enhance immune evasion via increased gene dosage. Positive selection is broadly distributed and likely driven by host immune pressure. Whether positive selection outside PvdbpII is relevant for vaccine design requires further investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.